GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shanghai Labway Clinical Laboratory Co Ltd (SZSE:301060) » Definitions » Revenue

Shanghai Labway Clinical Laboratory Co (SZSE:301060) Revenue : ¥1,698 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Labway Clinical Laboratory Co Revenue?

Shanghai Labway Clinical Laboratory Co's revenue for the three months ended in Mar. 2024 was ¥436 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,698 Mil. Shanghai Labway Clinical Laboratory Co's Revenue per Share for the three months ended in Mar. 2024 was ¥1.10. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4.25.

Warning Sign:

Shanghai Labway Clinical Laboratory Co Ltd revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Shanghai Labway Clinical Laboratory Co was -55.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 17.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 9 years, Shanghai Labway Clinical Laboratory Co's highest 3-Year average Revenue per Share Growth Rate was 47.40% per year. The lowest was 6.00% per year. And the median was 14.70% per year.


Shanghai Labway Clinical Laboratory Co Revenue Historical Data

The historical data trend for Shanghai Labway Clinical Laboratory Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Labway Clinical Laboratory Co Revenue Chart

Shanghai Labway Clinical Laboratory Co Annual Data
Trend Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only 1,153.50 1,238.19 1,778.33 4,199.31 1,674.37

Shanghai Labway Clinical Laboratory Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 412.59 425.32 431.97 404.49 436.44

Competitive Comparison of Shanghai Labway Clinical Laboratory Co's Revenue

For the Diagnostics & Research subindustry, Shanghai Labway Clinical Laboratory Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Labway Clinical Laboratory Co's Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shanghai Labway Clinical Laboratory Co's Revenue distribution charts can be found below:

* The bar in red indicates where Shanghai Labway Clinical Laboratory Co's Revenue falls into.



Shanghai Labway Clinical Laboratory Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,698 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Labway Clinical Laboratory Co  (SZSE:301060) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Shanghai Labway Clinical Laboratory Co Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai Labway Clinical Laboratory Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Labway Clinical Laboratory Co (SZSE:301060) Business Description

Traded in Other Exchanges
N/A
Address
Lane 268, Linxin Road, Floor 6, 7, 8, 9 of Building 1, Changning District, Shanghai, CHN, 200335
Labway Clinical Laboratory (Shanghai) Ltd provides comprehensive health management solutions relying on medical laboratory and pathological diagnosis services. It offers genetic testing, clinical microbiology testing, blood and pathology testing, cytopathological diagnosis and other services.
Executives
Sun Lin Jie Director

Shanghai Labway Clinical Laboratory Co (SZSE:301060) Headlines

No Headlines